Kala Pharmaceuticals Inc. (KALA)
6.65
0.10 (1.53%)
At close: Jan 14, 2025, 3:59 PM
7.10
6.76%
After-hours Jan 14, 2025, 05:16 PM EST
undefined% (undefined)
| Bid | 5.88 |
| Market Cap | 30.66M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -11.67 |
| PE Ratio (ttm) | -0.57 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 7.2 |
| Volume | 19,468 |
| Avg. Volume (20D) | 36,393 |
| Open | 6.62 |
| Previous Close | 6.55 |
| Day's Range | 6.52 - 6.74 |
| 52-Week Range | 4.21 - 9.25 |
| Beta | undefined |
About KALA
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye ...
Sector Healthcare
IPO Date Jul 20, 2017
Employees 43
Stock Exchange NASDAQ
Ticker Symbol KALA
Website https://www.kalarx.com
Analyst Forecast
According to 2 analyst ratings, the average rating for KALA stock is "Buy." The 12-month stock price forecast is $15, which is an increase of 125.56% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
6 months ago ·
Source
+40.22%
KALA BIO shares are trading higher. The company an...
Unlock content with
Pro Subscription
